DLH Reports Fiscal 2022 First Quarter Results
DLH Holdings Corp. (NASDAQ: DLHC) reported impressive financial results for the fiscal first quarter of 2022, with revenue soaring to $152.8 million, up from $57.9 million in the prior year, largely due to FEMA contracts in Alaska. Earnings were $7.8 million or $0.55 per diluted share compared to $1.8 million or $0.13 per diluted share in 2021. Notably, the company reduced its term debt to $42.9 million from $46.8 million. Contract backlog stood at $633.6 million, indicating strong future revenue potential despite expected declines in the second quarter.
- Revenue increased to $152.8 million from $57.9 million year-over-year.
- Earnings rose to $7.8 million, or $0.55 per diluted share, compared to $1.8 million, or $0.13 per diluted share in the prior year.
- Term debt reduced to $42.9 million from $46.8 million.
- Contract backlog reached $633.6 million.
- Revenue contribution from FEMA contracts is expected to decline in the fiscal second quarter.
Revenue
ATLANTA, Jan. 31, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal first quarter ended December 31, 2021.
Highlights
- First quarter revenue increased to
$152.8 million in fiscal 2022 from$57.9 million in fiscal 2021, reflecting the previously-announced award of two FEMA contracts to support Alaska, which accounted for approximately$91.1 million of revenue; these programs are expected to contribute substantially less revenue in the fiscal second quarter as performance nears completion - Excluding these short-term contracts, first quarter revenue rose to
$61.7 million in fiscal 2022, an increase of7% over the prior-year period - Earnings were
$7.8 million , or$0.55 per diluted share, for the fiscal 2022 first quarter versus$1.8 million , or$0.13 per diluted share, for the first quarter of fiscal 2021 - Excluding contributions from the aforementioned short-term FEMA contracts, earnings on a non-GAAP basis for the fiscal 2022 first quarter were
$3.1 million , or$0.22 per diluted share - The Company's term loan was reduced to
$42.9 million from$46.8 million during the first quarter - Contract backlog was
$633.6 million as of December 31, 2021 of which approximately$30.0 million related to the task order under a FEMA contract providing medical staffing support to Alaska, which is expected to be completed in the second quarter.
Management Discussion
“We delivered another solid quarter of growth at the start of fiscal 2022, resulting in outstanding performance that reflects the contribution of two short-term contracts, awarded by the DHS’ FEMA organization, for COVID-19 countermeasures and contingency assistance in Alaska,” said DLH President and Chief Executive Officer Zach Parker. “Excluding these programs, revenue rose almost
“The second quarter is expected to reflect the wind-down of our COVID-19 support activities in Alaska, but we remain on track for another year of standout results. M&A remains a key aspect of our expansion strategy as we examine opportunities to further strengthen our innovation and technology credentials and service offerings. In addition, we will continue to de-lever the balance sheet while enhancing our capital deployment plans, positioning the company for further growth; we believe the best is yet to come for DLH.”
Results for the Three Months Ended December 31, 2021
Revenue for the first quarter of fiscal 2022 was
Income from operations was
Interest expense was
For the three months ended December 31, 2021 and 2020, respectively, DLH recorded a
On a non-GAAP basis, EBITDA for the three months ended December 31, 2021 was approximately
Key Financial Indicators
Fiscal year to date, DLH used
As of December 31, 2021, the Company had cash and cash equivalents of
At December 31, 2021, total backlog was approximately
Conference Call and Webcast Details
DLH management will discuss first quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 10:00 AM Eastern Time tomorrow, February 1, 2022. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.
A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 8200479.
About DLH
DLH (NASDAQ:DLHC) delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,300 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of acquisitions; the challenges of managing larger and more widespread operations; contract awards in connection with re-competes for present business and/or competition for new business; compliance with new bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of acquisitions; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.
Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.
CONTACTS:
INVESTOR RELATIONS |
Contact: Chris Witty |
Phone: 646-438-9385 |
Email: cwitty@darrowir.com |
DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands except per share amounts)
(unaudited) | ||||||
Three Months Ended | ||||||
December 31, | ||||||
2021 | 2020 | |||||
Revenue | $ | 152,801 | $ | 57,852 | ||
Cost of Operations: | ||||||
Contract costs | 132,686 | 46,005 | ||||
General and administrative costs | 6,911 | 6,150 | ||||
Depreciation and amortization | 1,985 | 2,062 | ||||
Total operating costs | 141,582 | 54,217 | ||||
Income from operations | 11,219 | 3,635 | ||||
Interest expense, net | 672 | 1,080 | ||||
Income before income taxes | 10,547 | 2,555 | ||||
Income tax expense | 2,743 | 741 | ||||
Net income | $ | 7,804 | $ | 1,814 | ||
Net income per share - basic | $ | 0.61 | $ | 0.15 | ||
Net income per share - diluted | $ | 0.55 | $ | 0.13 | ||
Weighted average common shares outstanding | ||||||
Basic | 12,749 | 12,498 | ||||
Diluted | 14,295 | 13,445 |
DLH HOLDINGS CORP.
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands except par value of shares)
December 31, 2021 | September 30, 2021 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 4,221 | $ | 24,051 | ||||
Accounts receivable | 46,843 | 33,447 | ||||||
Other current assets | 4,897 | 4,265 | ||||||
Total current assets | 55,961 | 61,763 | ||||||
Equipment and improvements, net | 1,573 | 1,912 | ||||||
Operating lease right-of-use-assets | 18,562 | 19,919 | ||||||
Goodwill | 65,643 | 65,643 | ||||||
Intangible assets, net | 45,823 | 47,469 | ||||||
Other long-term assets | 431 | 464 | ||||||
Total assets | $ | 187,993 | $ | 197,170 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Operating lease liabilities - current | $ | 2,192 | $ | 2,261 | ||||
Accrued payroll | 10,976 | 9,125 | ||||||
Deferred revenue | 10,148 | 22,273 | ||||||
Accounts payable, accrued expenses, and other current liabilities | 30,383 | 32,717 | ||||||
Total current liabilities | 53,699 | 66,376 | ||||||
Long-term liabilities: | ||||||||
Deferred taxes, net | 1,176 | 1,176 | ||||||
Operating lease liabilities - long-term | 18,127 | 19,374 | ||||||
Debt obligations - long-term, net of deferred financing costs | 40,879 | 44,636 | ||||||
Total long-term liabilities | 60,182 | 65,186 | ||||||
Total liabilities | 113,881 | 131,562 | ||||||
Shareholders' equity: | ||||||||
Common stock, | 13 | 13 | ||||||
Additional paid-in capital | 88,593 | 87,893 | ||||||
Accumulated deficit | (14,494 | ) | (22,298 | ) | ||||
Total shareholders’ equity | 74,112 | 65,608 | ||||||
Total liabilities and shareholders' equity | $ | 187,993 | $ | 197,170 |
DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(unaudited) | ||||||||
Three Months Ended | ||||||||
December 31, | ||||||||
2021 | 2020 | |||||||
Operating activities | ||||||||
Net income | $ | 7,804 | $ | 1,814 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 1,985 | 2,062 | ||||||
Amortization of deferred financing costs charged to interest expense | 151 | 210 | ||||||
Stock based compensation expense | 500 | 458 | ||||||
Deferred taxes, net | — | 626 | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable | (13,396 | ) | (12,344 | ) | ||||
Other current assets | (632 | ) | 284 | |||||
Accrued payroll | 1,851 | (538 | ) | |||||
Deferred revenue | (12,125 | ) | — | |||||
Accounts payable, accrued expenses, and other current liabilities | (2,335 | ) | (1,185 | ) | ||||
Other long-term assets and liabilities | 42 | 95 | ||||||
Net cash used in operating activities | (16,155 | ) | (8,518 | ) | ||||
Investing activities | ||||||||
Purchase of equipment and improvements | — | (53 | ) | |||||
Net cash used in investing activities | — | (53 | ) | |||||
Financing activities | ||||||||
Proceeds from debt obligations | 6,000 | 9,150 | ||||||
Repayment of debt obligations | (9,875 | ) | (1,750 | ) | ||||
Payment of deferred financing costs | — | (41 | ) | |||||
Proceeds from issuance of common stock upon exercise of options and warrants | 200 | 225 | ||||||
Net cash provided by (used in) financing activities | (3,675 | ) | 7,584 | |||||
Net change in cash and cash equivalents | (19,830 | ) | (987 | ) | ||||
Cash and cash equivalents at beginning of year | 24,051 | 1,357 | ||||||
Cash and cash equivalents at end of year | $ | 4,221 | $ | 370 | ||||
Supplemental disclosure of cash flow information | ||||||||
Cash paid during the period for interest | $ | 513 | $ | 852 |
Revenue Metrics
Three Months Ended | ||||||
December 31, | December 31, | |||||
2021 | 2020 | |||||
Market Mix: | ||||||
Defense/VA | 24 | % | 60 | % | ||
Human Services and Solutions | 65 | % | 13 | % | ||
Public Health/Life Sciences | 11 | % | 27 | % | ||
Contract Mix: | ||||||
Time and Materials | 87 | % | 77 | % | ||
Cost Reimbursable | 7 | % | 20 | % | ||
Firm Fixed Price | 6 | % | 3 | % | ||
Prime vs Sub: | ||||||
Prime | 96 | % | 89 | % | ||
Subcontractor | 4 | % | 11 | % |
Non-GAAP Financial Measures
The Company uses EBITDA and EBITDA as a percent of revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA as a percent of revenue is EBITDA for the measurement period divided by revenue for the same period.
The Company is presenting additional non-GAAP measures to describe the impact from two short-term FEMA task orders' on its financial performance for the three months ended December 31, 2021. The measures presented are revenue, net income, diluted earnings per share, and EBITDA for the enterprise contract portfolio less the respective performance on the FEMA task orders. These resulting measures present the remaining contract portfolio's quarterly financial performance compared to results delivered in the prior-year period. Definitions of these additional non-GAAP measures are set forth in the footnotes to the reconciliation table below.
These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.
Reconciliation of GAAP net income to EBITDA, a non-GAAP measure (in thousands):
Three Months Ended | ||||||||||||
December 31, | ||||||||||||
2021 | 2020 | Change | ||||||||||
Net income | $ | 7,804 | $ | 1,814 | $ | 5,990 | ||||||
(i) Interest expense, net | 672 | 1,080 | (408 | ) | ||||||||
(ii) Provision for taxes | 2,743 | 741 | 2,002 | |||||||||
(iii) Depreciation and amortization | 1,985 | 2,062 | (77 | ) | ||||||||
EBITDA | $ | 13,204 | $ | 5,697 | $ | 7,507 | ||||||
Net income as a % of revenue | 5.1 | % | 3.1 | % | 2.0 | % | ||||||
EBITDA as a % of revenue | 8.6 | % | 9.8 | % | (1.2 | )% | ||||||
Revenue | $ | 152,801 | $ | 57,852 | $ | 94,949 |
Reconciliation of GAAP revenue, net income, diluted earnings per share and non-GAAP EBITDA reported for the fiscal quarter to the same metrics for our contract portfolio less the FEMA task orders:
Three Months Ended | ||||||||||
(amounts in thousands) | December 31, | |||||||||
Ref | 2021 | 2020 | Change | |||||||
Revenue | ||||||||||
Total enterprise | $ | 152,801 | $ | 57,852 | $ | 94,949 | ||||
Less: FEMA task orders to support Alaska | (a) | 91,125 | — | 91,125 | ||||||
Remaining contract portfolio | (a) | $ | 61,676 | $ | 57,852 | $ | 3,824 | |||
Net income | ||||||||||
Total enterprise | $ | 7,804 | $ | 1,814 | $ | 5,990 | ||||
Less: FEMA task orders to support Alaska | (b) | 4,696 | — | 4,696 | ||||||
Remaining contract portfolio | (b) | $ | 3,108 | $ | 1,814 | $ | 1,294 | |||
Diluted earnings per share | ||||||||||
Total enterprise | $ | 0.55 | $ | 0.13 | $ | 0.42 | ||||
Less: FEMA task orders to support Alaska | (c) | 0.33 | — | 0.33 | ||||||
Remaining contract portfolio | (c) | $ | 0.22 | $ | 0.13 | $ | 0.09 | |||
EBITDA | ||||||||||
Total enterprise | $ | 13,204 | $ | 5,697 | $ | 7,507 | ||||
Less: FEMA task orders to support Alaska | (d) | 6,346 | — | 6,346 | ||||||
Remaining contract portfolio | (d) | $ | 6,858 | $ | 5,697 | $ | 1,161 |
Ref (a): Revenue for the Company’s remaining contract portfolio less the FEMA task orders represents our consolidated revenues less the revenues generated from the FEMA task orders.
Ref (b): Net income attributable to the remaining contract portfolio less the FEMA task orders represents the Company’s consolidated net income, determined in accordance with GAAP, less the net income derived from the FEMA task orders. Net income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended December 31, 2021 of
Ref (c): Diluted earnings per share (diluted EPS) for the FEMA task orders is calculated using the net income attributable to such task orders as opposed to GAAP net income. Diluted EPS for the remaining contract portfolio (total contract portfolio excluding the FEMA task orders) is calculated by subtracting the diluted EPS for the FEMA task orders from the Company's total diluted EPS.
Ref (d): EBITDA attributable to the FEMA tasks orders of
FAQ
What were DLHC's earnings for the first quarter of fiscal 2022?
How did DLHC's revenue change compared to the previous year?
What is DLHC's current contract backlog?
What impact will FEMA contracts have on DLHC's future revenue?